ES2194515T3 - Estereotipia en animales. - Google Patents
Estereotipia en animales.Info
- Publication number
- ES2194515T3 ES2194515T3 ES99949158T ES99949158T ES2194515T3 ES 2194515 T3 ES2194515 T3 ES 2194515T3 ES 99949158 T ES99949158 T ES 99949158T ES 99949158 T ES99949158 T ES 99949158T ES 2194515 T3 ES2194515 T3 ES 2194515T3
- Authority
- ES
- Spain
- Prior art keywords
- oil
- stomach
- fibre
- omeprazole
- antagonists
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241001465754 Metazoa Species 0.000 title abstract 4
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 abstract 4
- 210000002784 stomach Anatomy 0.000 abstract 4
- 239000000835 fiber Substances 0.000 abstract 3
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical class N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 abstract 2
- -1 alkaline salt compounds Chemical class 0.000 abstract 2
- 229940069428 antacid Drugs 0.000 abstract 2
- 239000003159 antacid agent Substances 0.000 abstract 2
- 239000005557 antagonist Substances 0.000 abstract 2
- 239000003925 fat Substances 0.000 abstract 2
- 235000019197 fats Nutrition 0.000 abstract 2
- 229960001340 histamine Drugs 0.000 abstract 2
- 229960000381 omeprazole Drugs 0.000 abstract 2
- 229940126409 proton pump inhibitor Drugs 0.000 abstract 2
- 239000000612 proton pump inhibitor Substances 0.000 abstract 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 240000004658 Medicago sativa Species 0.000 abstract 1
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 abstract 1
- 235000019482 Palm oil Nutrition 0.000 abstract 1
- 206010042008 Stereotypy Diseases 0.000 abstract 1
- 235000019486 Sunflower oil Nutrition 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 abstract 1
- 230000001458 anti-acid effect Effects 0.000 abstract 1
- 230000006399 behavior Effects 0.000 abstract 1
- 239000000828 canola oil Substances 0.000 abstract 1
- 235000019519 canola oil Nutrition 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 230000001055 chewing effect Effects 0.000 abstract 1
- 229960001380 cimetidine Drugs 0.000 abstract 1
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 abstract 1
- 239000003240 coconut oil Substances 0.000 abstract 1
- 235000019864 coconut oil Nutrition 0.000 abstract 1
- 239000002285 corn oil Substances 0.000 abstract 1
- 235000005687 corn oil Nutrition 0.000 abstract 1
- 239000002540 palm oil Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 abstract 1
- 229960000620 ranitidine Drugs 0.000 abstract 1
- 235000021003 saturated fats Nutrition 0.000 abstract 1
- 229910000029 sodium carbonate Inorganic materials 0.000 abstract 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 abstract 1
- 235000012424 soybean oil Nutrition 0.000 abstract 1
- 239000002600 sunflower oil Substances 0.000 abstract 1
- 235000015112 vegetable and seed oil Nutrition 0.000 abstract 1
- 239000008158 vegetable oil Substances 0.000 abstract 1
- 239000002023 wood Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/20—Feeding-stuffs specially adapted for particular animals for horses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Animal Husbandry (AREA)
- Birds (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Fodder In General (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Catching Or Destruction (AREA)
Abstract
Utilización de una composición que comprende grasa, fibra y opcionalmente un antiácido gástrico, para la preparación de un medicamento para la mejora, el tratamiento o la prevención de estereotipias en animales, en la que la cantidad de grasa está comprendida entre el 5 % y el 20 % en peso de la composición, y la cantidad de fibra en la composición comprendida entre el 3, 5 % y el 35 % de fibra bruta, o entre el 15 % y el 70 % de fibra neutra detergente en peso de la composición.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9821790.4A GB9821790D0 (en) | 1998-10-06 | 1998-10-06 | Animal stereotypy |
| GBGB9822563.4A GB9822563D0 (en) | 1998-10-06 | 1998-10-15 | Animal stereotypy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2194515T3 true ES2194515T3 (es) | 2003-11-16 |
Family
ID=26314468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES99949158T Expired - Lifetime ES2194515T3 (es) | 1998-10-06 | 1999-10-06 | Estereotipia en animales. |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1119366B1 (es) |
| AT (1) | ATE235247T1 (es) |
| AU (1) | AU773696B2 (es) |
| CA (1) | CA2346646A1 (es) |
| DE (1) | DE69906335T2 (es) |
| ES (1) | ES2194515T3 (es) |
| GB (1) | GB2342292A (es) |
| WO (1) | WO2000020016A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2358136A (en) * | 2000-01-15 | 2001-07-18 | Univ Montfort | A medicament for the treatment of equine oral stereotypies using a pH regulator |
| SE0101379D0 (sv) * | 2001-04-18 | 2001-04-18 | Diabact Ab | Komposition som hämmar utsöndring av magsyra |
| SE0203065D0 (sv) | 2002-10-16 | 2002-10-16 | Diabact Ab | Gastric acid secretion inhibiting composition |
| US7824706B2 (en) * | 2003-05-09 | 2010-11-02 | Freedom Health, Llc | Dietary supplement and method for the treatment of digestive tract ulcers in equines |
| GB0312485D0 (en) * | 2003-05-30 | 2003-07-09 | Dodson & Horrell | Horse food composition |
| EP3054783B1 (en) * | 2013-10-09 | 2019-05-15 | Nutrition Sciences N.V. | Composition of medium chain fatty acids and fodder supplemented with same |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU407324B2 (en) * | 1962-05-01 | 1970-10-28 | Smith, Kline & French Laboratories | Powdered silicone products and processes |
| AU561597B2 (en) * | 1984-01-25 | 1987-05-14 | Mitsui Toatsu Chemicals Inc. | Feed additive composition |
| EP0222881A4 (en) * | 1985-05-10 | 1987-09-02 | Pharmacontrol Corp | PROLONGED ANTIACID COMPOSITIONS. |
| GB2200027A (en) * | 1987-01-16 | 1988-07-27 | Rin Rin International Corp | An animal feed |
| EP0280490A1 (en) * | 1987-02-25 | 1988-08-31 | R.J. SEAMAN & SONS LIMITED | Animal feedstuff |
| SE9301489D0 (sv) * | 1993-04-30 | 1993-04-30 | Ab Astra | Veterinary composition |
| AUPN033894A0 (en) * | 1994-12-29 | 1995-01-27 | Rowe, J.B. | Prevention of adverse behaviour in humans and animals |
| ATE228855T1 (de) * | 1995-04-03 | 2002-12-15 | Poul Bachmann | Pektin und ein phospholipid enthaltendes arzneimittel zur verwendung gegen durchfall und magengeschwüre |
| US5708017A (en) * | 1995-04-04 | 1998-01-13 | Merck & Co., Inc. | Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors |
| JPH09262061A (ja) * | 1996-03-28 | 1997-10-07 | Tanabe Seiyaku Co Ltd | ストレス緩和用飼料 |
| WO1998043644A1 (en) * | 1997-03-31 | 1998-10-08 | David Granstrom | Formulations and methods to treat and prevent equine protozoal myeloencephalitis |
| EP1061924A1 (en) * | 1998-03-09 | 2000-12-27 | Trustees Of Tufts College | Treatment of compulsive behaviours in man and animals |
-
1999
- 1999-10-06 ES ES99949158T patent/ES2194515T3/es not_active Expired - Lifetime
- 1999-10-06 CA CA002346646A patent/CA2346646A1/en not_active Abandoned
- 1999-10-06 EP EP99949158A patent/EP1119366B1/en not_active Expired - Lifetime
- 1999-10-06 WO PCT/GB1999/003288 patent/WO2000020016A1/en not_active Ceased
- 1999-10-06 DE DE69906335T patent/DE69906335T2/de not_active Expired - Lifetime
- 1999-10-06 GB GB9923639A patent/GB2342292A/en not_active Withdrawn
- 1999-10-06 AU AU62145/99A patent/AU773696B2/en not_active Expired
- 1999-10-06 AT AT99949158T patent/ATE235247T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU773696B2 (en) | 2004-06-03 |
| AU6214599A (en) | 2000-04-26 |
| GB9923639D0 (en) | 1999-12-08 |
| EP1119366B1 (en) | 2003-03-26 |
| WO2000020016A1 (en) | 2000-04-13 |
| EP1119366A1 (en) | 2001-08-01 |
| GB2342292A8 (en) | 2000-05-11 |
| GB2342292A (en) | 2000-04-12 |
| DE69906335D1 (de) | 2003-04-30 |
| CA2346646A1 (en) | 2000-04-13 |
| ATE235247T1 (de) | 2003-04-15 |
| DE69906335T2 (de) | 2004-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0309696A (pt) | Métodos e composições para o tratamento de infestação de ectoparasita | |
| RU2005140663A (ru) | Кормовая композиция для домашних животных с высоким содержанием протеина, низким содержанием углеводов, содержащая неферментируемую клетчатку | |
| CA2433484A1 (en) | Composition for use in animal nutrition comprising a controlled release lipid matrix, method for preparing the composition and method for the treatment of monogastric animals | |
| DK1460893T3 (da) | Strøelse til dyr | |
| ATE126972T1 (de) | Formulierung zur behandlung von silage. | |
| ES2190596T3 (es) | Pienso para animales que contiene acidos carboxilicos. | |
| Anindo et al. | Effect of molasses-urea-block (MUB) on dry matter intake, growth, reproductive performance and control of gastrointestinal nematode infection of grazing Menz ram lambs | |
| PT1178736E (pt) | Composicao que contem carvacrol e timol para utilizacao como bactericida | |
| ATE336177T1 (de) | Hypoallergene diätetische zusammensetzung für haustiere. | |
| FR2785807B1 (fr) | Formulation de complement alimentaire, composition alimentaire la comprenant, ses utilisations | |
| Puga et al. | Effect of a controlled-release urea supplement on rumen fermentation in sheep fed a diet of sugar cane tops (Saccharum officinarum), corn stubble (Zea mays) and King grass (Pennisetum purpureum) | |
| GB9923639D0 (en) | Animal stereotypy | |
| Richardson et al. | Sunflower meal as a protein supplement for growing ruminants | |
| Knox et al. | Urea-molasses blocks for parasite control | |
| Samuelsen et al. | Influence of dietary recombinant microbial lipase on performance and quality characteristics of rainbow trout, Oncorhynchus mykiss | |
| WO2005027636A3 (en) | Improved topical treatment for the eradication and/or control of ectoparasites | |
| TR200401001T4 (tr) | Safra asitleri içeren hayvancılık teknolojisi formülasyonları. | |
| BR9406629A (pt) | Composições antiacidas liquidas | |
| MY138235A (en) | Feed additive compositions for animals comprising polyethoxylated ascorbic acid derivatives | |
| HUT62474A (en) | Process for producing veterinary composition with antiparasitic effect | |
| EP1128737B8 (en) | Use of growth enhancing feed additives | |
| US7534463B1 (en) | Use of a novel source of fiber for captive wild browser diets | |
| RU2089195C1 (ru) | Способ профилактики некробактериоза животных | |
| Das et al. | Effect of glucosinolates of taramira (Eruca sativa) oilcake on nutrient utilization and growth of crossbred calves | |
| Nguyen | Treatment and supplementation of rice straw for ruminant feeding in Vietnam. |